Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)

被引：0
|
作者：
Lee Schwartzberg
Sally Y. Barbour
Gary R. Morrow
Gianluca Ballinari
Michael D. Thorn
David Cox
机构：
[1] West Clinic,Department of Pharmacy
[2] Duke University Medical Center,undefined
[3] University of Rochester School of Medicine and Dentistry,undefined
[4] Helsinn Healthcare SA,undefined
[5] Statistics Resources,undefined
[6] Inc.,undefined
[7] Eisai Inc.,undefined
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Palonosetron; Serotonin antagonists; CINV; Nausea; Vomiting; Cancer chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：469 / 477
页数：8
相关论文
共 50 条
  • [21] Netupitant/palonosetron (NEPA) for prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in multiple cycles of chemotherapy.
    Schwartzberg, Lee Steven
    Gralla, Richard J.
    Kashef, Kimia
    Rugo, Hope
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [22] Palonosetron (PALO) versus ondanestron/dolasetron (OND/DOL) in preventing chemotherapy-induced nausea and vomiting (CINV) in elderly patients: Combined results from 2 phase III trials.
    Aapro, MS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 741S - 741S
  • [23] Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis
    Yu-Chen Hsu
    Ching-Yao Chen
    Ka-Wai Tam
    Chin-Yu Hsu
    European Journal of Clinical Pharmacology, 2021, 77 : 1597 - 1609
  • [24] Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis
    Hsu, Yu-Chen
    Chen, Ching-Yao
    Tam, Ka-Wai
    Hsu, Chin-Yu
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (11) : 1597 - 1609
  • [25] Palonosetron versus ondansetron as prophylaxis of chemotherapy-induced nausea and vomiting: a single-centre experience
    Tendas, A.
    Niscola, P.
    Cupelli, L.
    Trawinska, M. M.
    Abruzzese, E.
    Siniscalchi, A.
    Caravita, T.
    Scaramucci, L.
    Giovannini, M.
    Angelini, S.
    Perrotti, A. P.
    Dentamaro, T.
    Arcese, W.
    De Fabritiis, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S174 - S174
  • [26] Dronabinol or ondansetron alone and combined for delayed chemotherapy-induced nausea and vomiting (CINV).
    Jhangiani, H
    Vredenburgh, JJ
    Barbato, L
    Yang, HC
    Yang, HM
    Baranowski, V
    Tse, N
    BLOOD, 2005, 106 (11) : 477B - 477B
  • [27] Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting
    Keating, Gillian M.
    DRUGS, 2015, 75 (18) : 2131 - 2141
  • [28] Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting
    Gillian M. Keating
    Drugs, 2015, 75 : 2131 - 2141
  • [29] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer
    Navari, Rudolph M.
    FUTURE ONCOLOGY, 2010, 6 (07) : 1073 - 1084
  • [30] A multicycle phase III study evaluating palonosetron vs ondansetron at preventing chemotherapy-induced nausea and vomiting in pediatric patients
    Kabickova, E.
    Wachtel, A.
    Basharova, E.
    Spinelli, T.
    Nicolas, P.
    Kovacs, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S237 - S237
12345